01:51 PM EST, 03/06/2024 (MT Newswires) -- NeuroPace ( NPCE ) shares were down 4.6% in recent trading on Wednesday, a day after the company announced its Q4 earnings.

The company reported Q4 net loss Tuesday of $0.23 per diluted share, compared with a net loss of $0.45 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.31.

Revenue for the quarter ended Dec. 31 was $18 million, up from $12.8 million a year earlier.

Analysts surveyed by Capital IQ expected $17.8 million.

The medical device company said it expects full year revenue to range between $73 million and $77 million. Analysts polled by Capital IQ expect $75.3 million.

Price: 13.55, Change: -0.65, Percent Change: -4.58